Integrated Cardiac Safety
Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance| By: | J. Rick Turner; Todd A. Durham |
| Publisher: | Wiley Global Research (STMS) |
| Print ISBN: | 9780470229644 |
| eText ISBN: | 9780470411285 |
| Edition: | 1 |
| Copyright: | 2009 |
| Format: | Page Fidelity |
eBook Features
Instant Access
Purchase and read your book immediately
Read Offline
Access your eTextbook anytime and anywhere
Study Tools
Built-in study tools like highlights and more
Read Aloud
Listen and follow along as Bookshelf reads to you
The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.